Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study (BMC Psychiatry, (2021), 21, 1, (622), 10.1186/s12888-021-03608-1)

Maggie McCue; Sara Sarkey; Anna Eramo; Clement François; Sagar V. Parikh

ArticleOPEN ACCESS

Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study (BMC Psychiatry, (2021), 21, 1, (622), 10.1186/s12888-021-03608-1)

BMC Psychiatry

DOI: 10.1186/s12888-022-03798-2

3Citations

6Readers

Abstract

Following publication of the original article [1], the authors identified errors in the text. Below is a table of corrections which have been implemented in the original article.

Cite

CITATION STYLE

APA

McCue, M., Sarkey, S., Eramo, A., François, C., & Parikh, S. V. (2022, December 1). Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study (BMC Psychiatry, (2021), 21, 1, (622), 10.1186/s12888-021-03608-1). BMC Psychiatry. BioMed Central Ltd. https://doi.org/10.1186/s12888-022-03798-2

Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study (BMC Psychiatry, (2021), 21, 1, (622), 10.1186/s12888-021-03608-1)

Abstract

Cite

Register to see more suggestions